These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11469527)

  • 1. Serglycin expression in CD2+ and CD14+ cells from patients with various rheumatic diseases.
    Omtvedt LA; Kolset SO; Thoen J; Førre Y; Gill MR
    Scand J Rheumatol; 2001; 30(3):164-6. PubMed ID: 11469527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of increased synovial fluid A disintegrin and metalloproteinase with thrombospondin motifs4 and serglycin levels in osteoarthritis.
    Özler K
    Ir J Med Sci; 2019 Aug; 188(3):867-872. PubMed ID: 30536194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serglycin-binding proteins in activated macrophages and platelets.
    Kolset SO; Mann DM; Uhlin-Hansen L; Winberg JO; Ruoslahti E
    J Leukoc Biol; 1996 Apr; 59(4):545-54. PubMed ID: 8613703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide.
    Zernichow L; Abrink M; Hallgren J; Grujic M; Pejler G; Kolset SO
    J Biol Chem; 2006 Sep; 281(37):26792-801. PubMed ID: 16807245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders.
    Denko CW; Aponte J; Gabriel P; Petricevic M
    Clin Rheumatol; 1986 Jan; 5(1):25-32. PubMed ID: 2937602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14 is an acute-phase protein.
    Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
    J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serglycin levels with isolated coronary artery ectasia.
    Kundi H; Gök M; Topçuoglu C; Ornek E
    Kardiol Pol; 2017; 75(10):990-996. PubMed ID: 28612914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serglycin expression during monocytic differentiation of U937-1 cells.
    Kulseth MA; Mustorp SL; Uhlin-Hansen L; Oberg F; Kolset SO
    Glycobiology; 1998 Aug; 8(8):747-53. PubMed ID: 9639535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
    Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
    Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serglycin is involved in inflammatory response in articular mouse chondrocytes.
    D'Ascola A; Scuruchi M; Avenoso A; Bruschetta G; Campo S; Mandraffino G; Campo GM
    Biochem Biophys Res Commun; 2018 May; 499(3):506-512. PubMed ID: 29588174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro.
    Reine TM; Vuong TT; Jenssen TG; Kolset SO
    Biochim Biophys Acta; 2014 Aug; 1840(8):2498-505. PubMed ID: 24513305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serglycin secreted by leukocytes is efficiently eliminated from the circulation by sinusoidal scavenger endothelial cells in the liver.
    Oynebråten I; Hansen B; Smedsrød B; Uhlin-Hansen L
    J Leukoc Biol; 2000 Feb; 67(2):183-8. PubMed ID: 10670578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.
    Sutton VR; Brennan AJ; Ellis S; Danne J; Thia K; Jenkins MR; Voskoboinik I; Pejler G; Johnstone RW; Andrews DM; Trapani JA
    FEBS J; 2016 Mar; 283(5):947-61. PubMed ID: 26756195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between serum serglycin level and coronary artery disease severity in patients with stable angina pectoris.
    Bolayır HA; Kıvrak T; Gunes H; Bolayır A; Karaca I
    Kardiol Pol; 2018; 76(4):783-790. PubMed ID: 29313562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.
    Cope AP; Aderka D; Doherty M; Engelmann H; Gibbons D; Jones AC; Brennan FM; Maini RN; Wallach D; Feldmann M
    Arthritis Rheum; 1992 Oct; 35(10):1160-9. PubMed ID: 1329774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The soluble interleukin-2 receptor in rheumatic disease.
    Rubin LA
    Arthritis Rheum; 1990 Aug; 33(8):1145-8. PubMed ID: 2390120
    [No Abstract]   [Full Text] [Related]  

  • 17. Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice.
    Roy A; Sawesi O; Pettersson U; Dagälv A; Kjellén L; Lundén A; Åbrink M
    BMC Immunol; 2016 Jun; 17(1):15. PubMed ID: 27267469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes.
    Schick BP; Jacoby JA
    J Cell Physiol; 1995 Oct; 165(1):96-106. PubMed ID: 7559813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-alpha and IL-1alpha.
    Kulseth MA; Kolset SO; Ranheim T
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):225-32. PubMed ID: 10434040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation and distribution of vitronectin in synovial fluid and tissue of patients with rheumatic disease.
    Rosenblum G; Carsons S
    Clin Exp Rheumatol; 1996; 14(1):31-6. PubMed ID: 8697654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.